Clinical trials
Completed Phase 3 Sleep Initiation and Maintenance Disorders trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
115 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 4 |
| 2003 | 7 |
| 2004 | 15 |
| 2005 | 11 |
| 2006 | 15 |
| 2007 | 10 |
| 2008 | 7 |
| 2009 | 4 |
| 2010 | 6 |
| 2011 | 5 |
| 2012 | 6 |
| 2013 | 3 |
| 2016 | 5 |
| 2017 | 2 |
| 2018 | 4 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 115 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| H. Lundbeck A/S | 10 |
| Sanofi | 10 |
| Takeda | 10 |
| Merck Sharp & Dohme LLC | 9 |
| Sumitomo Pharma America, Inc. | 9 |
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 8 |
| Karolinska Institutet | 4 |
| Astellas Pharma Inc | 3 |
| Eisai Inc. | 3 |
| Idorsia Pharmaceuticals Ltd. | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sleep Initiation and Maintenance Disorders | 115 |
| Sleep Wake Disorders | 11 |
| Major Depressive Disorder | 5 |
| Parasomnias | 5 |
| Alzheimer Disease | 4 |
| Anxiety Disorders | 4 |
| Mental Disorders | 4 |
| Attention Deficit Disorder with Hyperactivity | 3 |
| Dyssomnias | 3 |
| Sleep Disorders, Intrinsic | 3 |
Trials
Showing 1 to 25 of 115. Each trial links to its page on Pharma Observatory.
15 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.